These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24067562)

  • 1. Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes.
    Giacomet V; Cattaneo D; Viganò A; Nannini P; Manfredini V; Ramponi G; Clementi E; Zuccotti GV
    Pediatr Infect Dis J; 2013 Oct; 32(10):e403-5. PubMed ID: 24067562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study.
    Nishijima T; Komatsu H; Higasa K; Takano M; Tsuchiya K; Hayashida T; Oka S; Gatanaga H
    Clin Infect Dis; 2012 Dec; 55(11):1558-67. PubMed ID: 22955427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of tenofovir treatment.
    Rodriguez-Novoa S; Labarga P; Soriano V
    Pharmacogenomics; 2009 Oct; 10(10):1675-85. PubMed ID: 19842939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
    Rodríguez-Nóvoa S; Labarga P; Soriano V; Egan D; Albalater M; Morello J; Cuenca L; González-Pardo G; Khoo S; Back D; Owen A
    Clin Infect Dis; 2009 Jun; 48(11):e108-16. PubMed ID: 19400747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction.
    Pushpakom SP; Liptrott NJ; Rodríguez-Nóvoa S; Labarga P; Soriano V; Albalater M; Hopper-Borge E; Bonora S; Di Perri G; Back DJ; Khoo S; Pirmohamed M; Owen A
    J Infect Dis; 2011 Jul; 204(1):145-53. PubMed ID: 21628669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients.
    Calza L; Trapani F; Tedeschi S; Piergentili B; Manfredi R; Colangeli V; Viale P
    Scand J Infect Dis; 2011 Aug; 43(8):656-60. PubMed ID: 21453205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.
    Izzedine H; Hulot JS; Villard E; Goyenvalle C; Dominguez S; Ghosn J; Valantin MA; Lechat P; Deray AG
    J Infect Dis; 2006 Dec; 194(11):1481-91. PubMed ID: 17083032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.
    Likanonsakul S; Suntisuklappon B; Nitiyanontakij R; Prasithsirikul W; Nakayama EE; Shioda T; Sangsajja C
    PLoS One; 2016; 11(1):e0147724. PubMed ID: 26807589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.
    Salvaggio SE; Giacomelli A; Falvella FS; Oreni ML; Meraviglia P; Atzori C; Clementi EGI; Galli M; Rusconi S
    BMC Infect Dis; 2017 Jun; 17(1):396. PubMed ID: 28583112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen.
    Manosuthi W; Sukasem C; Thongyen S; Nilkamhang S; Sungkanuparph S
    J Antimicrob Chemother; 2014 Aug; 69(8):2195-201. PubMed ID: 24788661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir in HIV-infected children. Antiretroviral efficacy, but beware of adverse effects on bone and the kidneys.
    Prescrire Int; 2014 May; 23(149):124-5. PubMed ID: 24926511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tubular dysfunction associated with tenofovir therapy.
    Mitra S; Priscilla R; Rajeev K; Sauradeep S; Rajkumar S; Cherian AO
    J Assoc Physicians India; 2014 Jul; 62(7):580-2. PubMed ID: 25672029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlikely association of multidrug-resistance protein 2 single-nucleotide polymorphisms with tenofovir-induced renal adverse events.
    Ray AS; Cihlar T
    J Infect Dis; 2007 May; 195(9):1389-90; author reply 1390-1. PubMed ID: 17397012
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent bone fractures due to tenofovir-induced renal phosphate wasting.
    Koenig KF; Kalbermatter S; Menter T; Graber P; Kiss D
    Scand J Infect Dis; 2014 Mar; 46(3):221-4. PubMed ID: 24147545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of proximal renal tubular dysfunction in patients on tenofovir disoproxil fumarate.
    Quinn KJ; Emerson CR; Dinsmore WW; Donnelly CM
    Int J STD AIDS; 2010 Feb; 21(2):150-1. PubMed ID: 20090006
    [No Abstract]   [Full Text] [Related]  

  • 16. Tenofovir-induced osteomalacia.
    Wanner DP; Tyndall A; Walker UA
    Clin Exp Rheumatol; 2009; 27(6):1001-3. PubMed ID: 20149322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration.
    Ezinga M; Wetzels JF; Bosch ME; van der Ven AJ; Burger DM
    Antivir Ther; 2014; 19(8):765-71. PubMed ID: 24584104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
    Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
    AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir-related nephrotoxicity: an ongoing clinical challenge.
    Foisy MM; Hughes C; Hills-Nieminen C; Singh AE; Joffe AM
    Am J Health Syst Pharm; 2013 Aug; 70(15):1272-4. PubMed ID: 23867482
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal safety of tenofovir in HIV-infected children: a prospective, 96-week longitudinal study.
    Viganò A; Zuccotti GV; Martelli L; Giacomet V; Cafarelli L; Borgonovo S; Beretta S; Rombolà G; Mora S
    Clin Drug Investig; 2007; 27(8):573-81. PubMed ID: 17638398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.